FDA changing notices on drug decisions
WASHINGTON (Reuters) - U.S. regulators will change the way they tell drugmakers that their medicines are not ready to be approved, the Food and Drug Administration said on Wednesday.
<p><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=BysjCm" border="0"></img> (http://feeds.reuters.com/~a/reuters/healthNews?a=BysjCm)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/healthNews?i=51UkhJ" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=51UkhJ) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=eVcyej" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=eVcyej) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=Me91Zj" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=Me91Zj)
</div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/330864771" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/330864771/idUSN0939359620080709